AdvanCell reported raising $315 Million in an initial SEC Form D filing, from an offering of $315 Million
Round Type
Series D
SydneyBiotechnologyHealth CareTherapeuticsInvestors
Description
AdvanCell has successfully completed a $315 million Series D financing round. This oversubscribed funding will be used to further develop its targeted alpha therapies. Additionally, the capital will help expand their clinical and commercial manufacturing capabilities. The investment highlights the growing interest in innovative cancer therapies.
Quick answer
AdvanCell raised $315 Million in a Series D round, dated July 15, 2026. Investors: Proto Axiom, Catalio Capital Management, Piper Heartland, Brandon Capital, Tenmile, Symbiosis, Abingworth and Sanofi Ventures. AdvanCell is based in Sydney, New South Wales, Australia.
- How much did AdvanCell raise?
- AdvanCell raised $315 Million in a Series D round on July 15, 2026.
- Who invested in AdvanCell?
- Proto Axiom, Catalio Capital Management, Piper Heartland, Brandon Capital, Tenmile, Symbiosis, Abingworth and Sanofi Ventures are named as investors in this round.
- What does AdvanCell do?
- AdvanCell is a vertically integrated, clinical-stage radiopharmaceutical company dedicated to developing innovative cancer therapies that harness the power of targeted alpha-emitting radionuclides.
- Where is AdvanCell based and how big is it?
- AdvanCell is based in Sydney, New South Wales, Australia. Fundz records about 96 employees.
- Who are the decision-makers at AdvanCell?
- Fundz holds 1 contact at AdvanCell, including the Managing Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as AdvanCell that raised within 45 days of this round, from Fundz verified event records.
- AusperBio raised $120M (Series C) on August 28, 2026.
- BioLineRx Ltd raised $3.8M on August 27, 2026.
- Redx raised $36M (Series A) on August 27, 2026.
- Revier Therapeutics raised $7M (Seed) on August 25, 2026.
- Airway Therapeutics, LLC raised $50M (Series E) on August 25, 2026.
- Amylyx Pharmaceuticals raised $500M (Post-IPO Equity) on August 20, 2026.
Who to call at AdvanCell, and when
A new round usually means AdvanCell is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day AdvanCell raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at AdvanCell, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at AdvanCell. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment AdvanCell raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
AdvanCell raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.